Literature DB >> 11562759

Identification of candidate genes in ulcerative colitis and Crohn's disease using cDNA array technology.

S M Uthoff1, M R Eichenberger, R K Lewis, M P Fox, C J Hamilton, T L McAuliffe, H L Grimes, S Galandiuk.   

Abstract

Inflammatory bowel disease (IBD) follows a multigenic mode of inheritance, encompassing the clinically discrete phenotypes of ulcerative colitis (UC) and Crohn's disease (CD). The risk of malignant transformation of the colon increases with the duration and extent of IBD and is particularly high for patients with a longstanding history of UC. We wished to identify candidate genes that might be involved in disease pathogenesis based on functional plausibility and their putative role in IBD carcinogenesis. Polyadenylated mRNA (PolyA+ mRNA) preparation from inflamed intestinal mucosa of patients with a longstanding history of UC and CD was performed with subsequent hybridization of alpha phosphorus [alpha-32P]-deoxyadenotriphosphate-labeled complementary deoxyribonucleic acid (DNA) populations to nucleic acid arrays. Of 588 different human gene transcripts arrayed, secreted apoptosis-related protein 1 (Sarp1), frizzled (fz) homologues, and disheveled (dvl) were differentially expressed, being elevated in UC as compared to CD. These genes encode proteins involved in the Wingless-type (Wnt)/beta-catenin signaling pathway. The autonomous expression of Sarp1 and Sarp1-compatible fz receptor genes suggests that the Wnt pathway may be involved in UC carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11562759     DOI: 10.3892/ijo.19.4.803

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  11 in total

1.  Protective pathways against colitis mediated by appendicitis and appendectomy.

Authors:  R Cheluvappa; A S Luo; C Palmer; M C Grimm
Journal:  Clin Exp Immunol       Date:  2011-06-27       Impact factor: 4.330

2.  Persistence of gene expression changes in noninflamed and inflamed colonic mucosa in ulcerative colitis and their presence in colonic carcinoma.

Authors:  Yuji Toiyama; Akira Mizoguchi; Kazushi Kimura; Toshimitsu Araki; Shigeyuki Yoshiyama; Kouhei Sakaguchi; Chikao Miki; Masato Kusunoki
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

3.  PAR1b promotes cell-cell adhesion and inhibits dishevelled-mediated transformation of Madin-Darby canine kidney cells.

Authors:  Maya Elbert; David Cohen; Anne Müsch
Journal:  Mol Biol Cell       Date:  2006-05-17       Impact factor: 4.138

4.  Gene expression profile after peroxisome proliferator activator receptor-gamma ligand administration in dextran sodium sulfate mice.

Authors:  Atsushi Nakajima; Koichiro Wada; Kazufumi Katayama; Lawrence Saubermann; Emi Osawa; Hajime Nagase; Norio Ueno; Nobuyuki Matsuhashi; Hiroyuki Aburatani
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

5.  CARD15 status and familial predisposition for Crohn's disease and colonic gene expression.

Authors:  Claudio Csillag; Ole Haagen Nielsen; Rehannah Borup; Jørgen Olsen; Jacob Tveiten Bjerrum; Finn Cilius Nielsen
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

6.  Wnt pathway-related gene expression in inflammatory bowel disease.

Authors:  Joann You; Anthony V Nguyen; C Gregory Albers; Fritz Lin; Randall F Holcombe
Journal:  Dig Dis Sci       Date:  2007-10-16       Impact factor: 3.199

7.  Deoxycholate-induced colitis is markedly attenuated in Nos2 knockout mice in association with modulation of gene expression profiles.

Authors:  Harris Bernstein; Hana Holubec; Carol Bernstein; Natalia A Ignatenko; Eugene Gerner; Katerina Dvorak; David Besselsen; Karen Ann Blohm-Mangone; Jose Padilla-Torres; Barbora Dvorakova; Harinder Garewal; Claire M Payne
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.487

8.  An ileal Crohn's disease gene signature based on whole human genome expression profiles of disease unaffected ileal mucosal biopsies.

Authors:  Tianyi Zhang; Bowen Song; Wei Zhu; Xiao Xu; Qing Qing Gong; Christopher Morando; Themistocles Dassopoulos; Rodney D Newberry; Steven R Hunt; Ellen Li
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

9.  Expressing the differences between Crohn disease and ulcerative colitis.

Authors:  Cisca Wijmenga
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.069

10.  Immunohistochemical analysis of retinoblastoma and β-catenin as an assistant tool in the differential diagnosis between Crohn's disease and ulcerative colitis.

Authors:  Rossana Colla Soletti; Nathassya Accioly Lins Vidal Rodrigues; Deborah Biasoli; Ronir Raggio Luiz; Heitor Siffert Pereira de Souza; Helena Lobo Borges
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.